{"id":59795,"name":"OCULAR THREPEUTIX","slug":"ocular-threpeutix","state":"MA","country":"United States of America","description":"Biopharmaceutical company focused on therapies for the eye.","totalSpending":160000,"filings":10,"yearlySpending":[{"year":2024,"income":80000},{"year":2025,"income":80000}],"issues":[{"code":"MMM","display":"Medicare/Medicaid"}],"firms":["CAPITOL HILL CONSULTING GROUP"],"lobbyists":["EMILY WILKINSON-HOLLAND","CHRISTOPHER DAVIS","BRIAN SUTTER","KIMBERLEE TRZECIAK"],"govEntities":["Centers For Medicare and Medicaid Services (CMS)","Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Medicare reimbursement for ocular devices and therapies.","Medicare reimbursement for ocular devices and therapies.","Biopharmaceutical company focused on therapies for the eye.","Biopharmaceutical company focused on therapies for the eye. Issues related to Medicare reimbursement for therapies of the eye.","Biopharmaceutical company focused on therapies for the eye. Issues related to Medicare reimbursement for therapies of the eye."]}